Inactive Instrument

Occlutech Holding AG Stock

Equities

Duration

Period

Style

Occlutech Holding AG Continues its Progress in US FDA Study OCCLUFLEX – Enrolls First Patient in Europe	23-01-31	CI
Occlutech Holding AG Appoints Jozef Bartunek as New Chief Medical Officer	22-11-01	CI
Occlutech Holding AG Appoints Jose De La Cortina as Chief Commercial Officer	22-09-06	CI
Occlutech Holding AG announced that it has received SEK 450 million in funding from AP Fonden 4, Carnegie Investment Bank AB	21-12-20	CI
Occlutech Holding AG has withdrawn its IPO in the amount of SEK 963.8035 million.	21-09-28	CI
Occlutech Holding AG has filed an IPO in the amount of SEK 963.8035 million.	21-09-08	CI
Occlutech Holding AG announced that it has received funding from COI Partners	12-12-30	CI

Sector